RCE 0.97% 52.0¢ recce pharmaceuticals ltd

Ann: Recce Selects CMAX for Phase I/II UTI Clinical Trial, page-27

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 5,374 Posts.
    lightbulb Created with Sketch. 692
    In the recent spark presentation there seemed to be an additional dot point under the section for burns phase 1/2.

    "Domestic and International interest in study and study site expansion progressing, with expected advancement Q1 2023"

    If I'm not mistaken this would indicate there are about to be developments in this trial apparently within this quarter. Maybe this will be the trigger for the share price boost we currently need. I am so ready to gear some good news on this trial after those awesome initial results over a year ago now.
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
52.0¢
Change
0.005(0.97%)
Mkt cap ! $120.5M
Open High Low Value Volume
54.0¢ 54.0¢ 52.0¢ $4.485K 8.497K

Buyers (Bids)

No. Vol. Price($)
1 17 52.0¢
 

Sellers (Offers)

Price($) Vol. No.
53.0¢ 14897 2
View Market Depth
Last trade - 15.47pm 04/10/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.